- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/71 - ReceptorsCell surface antigensCell surface determinants for growth factorsReceptorsCell surface antigensCell surface determinants for growth regulators
Patent holdings for IPC class C07K 14/71
Total number of patents in this class: 2242
10-year publication summary
|
134
|
140
|
153
|
144
|
205
|
220
|
171
|
157
|
170
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 349 |
141 |
| Regeneron Pharmaceuticals, Inc. | 4541 |
133 |
| The Regents of the University of California | 20427 |
35 |
| Amgen Inc. | 4307 |
35 |
| Immatics Biotechnologies GmbH | 1133 |
31 |
| Keros Therapeutics, Inc. | 71 |
28 |
| The Trustees of the University of Pennsylvania | 4392 |
24 |
| Board of Regents, The University of Texas System | 6020 |
23 |
| The Board of Trustees of the Leland Stanford Junior University | 6589 |
21 |
| City of Hope | 1013 |
21 |
| Precigen Inc | 106 |
20 |
| Immunitybio, Inc. | 487 |
20 |
| Genentech, Inc. | 4050 |
19 |
| Genzyme Corporation | 1333 |
18 |
| The Johns Hopkins University | 5782 |
17 |
| Biocon Limited | 224 |
17 |
| Seattle Children's Hospital | 87 |
16 |
| Novartis AG | 10462 |
15 |
| Merck Patent GmbH | 5732 |
15 |
| National Research Council of Canada | 1564 |
15 |
| Other owners | 1578 |